- Home
- ORKA vs TWFG Comparison
ORKA vs TWFG Comparison
Compare ORKA & TWFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORKA
- TWFG
- Stock Information
- Founded
- ORKA 2004
- TWFG 2001
- Country
- ORKA United States
- TWFG United States
- Employees
- ORKA N/A
- TWFG N/A
- Industry
- ORKA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- TWFG
- Sector
- ORKA Health Care
- TWFG
- Exchange
- ORKA Nasdaq
- TWFG NYSE
- Market Cap
- ORKA 429.4M
- TWFG 437.4M
- IPO Year
- ORKA N/A
- TWFG 2024
- Fundamental
- Price
- ORKA $8.92
- TWFG $30.80
- Analyst Decision
- ORKA Strong Buy
- TWFG Buy
- Analyst Count
- ORKA 7
- TWFG 8
- Target Price
- ORKA $39.67
- TWFG $33.14
- AVG Volume (30 Days)
- ORKA 272.6K
- TWFG 93.1K
- Earning Date
- ORKA 03-06-2025
- TWFG 05-15-2025
- Dividend Yield
- ORKA N/A
- TWFG N/A
- EPS Growth
- ORKA N/A
- TWFG N/A
- EPS
- ORKA N/A
- TWFG 0.19
- Revenue
- ORKA N/A
- TWFG $203,760,000.00
- Revenue This Year
- ORKA N/A
- TWFG $22.49
- Revenue Next Year
- ORKA N/A
- TWFG $18.64
- P/E Ratio
- ORKA N/A
- TWFG $169.19
- Revenue Growth
- ORKA N/A
- TWFG 18.44
- 52 Week Low
- ORKA $8.66
- TWFG $21.31
- 52 Week High
- ORKA $53.88
- TWFG $36.50
- Technical
- Relative Strength Index (RSI)
- ORKA N/A
- TWFG N/A
- Support Level
- ORKA N/A
- TWFG N/A
- Resistance Level
- ORKA N/A
- TWFG N/A
- Average True Range (ATR)
- ORKA 0.00
- TWFG 0.00
- MACD
- ORKA 0.00
- TWFG 0.00
- Stochastic Oscillator
- ORKA 0.00
- TWFG 0.00
About ORKA Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel monoclonal antibody therapeutics for psoriasis (PsO) and other inflammatory and immunology (I&I) indications. Its lead program, ORKA-001, is designed to target the p19 subunit of interleukin-23 (IL-23p19) for the treatment of PsO. The company's co-lead program, ORKA-002, is designed to target interleukin-17A and interleukin-17F (IL-17A/F) for the treatment of PsO, psoriatic arthritis (PsA), and other conditions. These programs each bind their respective targets at high affinity and incorporate half-life extension technology to increase exposure and decreasing dosing frequency.
About TWFG TWFG INC
TWFG Inc is a independent distribution platform for personal and commercial insurance in the United States. It offers all lines of insurance, multiple distribution contract options, M&A services, proprietary virtual assistants, proprietary technology, proprietary premium financing, unlimited continuing education, recognition programs, co-op funding, marketing support and overall lower costs to operate.